Events
We are excited to invite you to our cancer screening events. Here, you can have one blood draw and select one or multiple tests, plus pick up kits for urine and stool kits that can be taken home. Our aim is to provide a simple, accessible, one-stop shop for multiple advanced cancer screening tests that we specialise in.
We will accommodate walk-in appointments on the day, but it’s best to get booked in prior to the event beforehand to avoid delays.
Event dates
23rd July 2024
4pm - 8pm
Freemasons Hall, Cambridge, CB2 1NA
Booking link: https://chaps.mypsatests.org.uk/events/?6c13ba44-606c-4b66-9005-8a03ac3e29ca
10th / 11th August 2024
10am - 5pm Saturday and Sunday
Cambridge Country Fair - www.cambridgecountryshow.co.uk/
Stow Road, Stow Cum Quy Park, Cambridge, CB25 9AJ
Expired events
4th July 2024
6pm - 9pm
Hascombe Farm, Horn Lane, Henfield, BN5 9SA
Booking link: https://www.sirkkahealth.com/group-testing
Available tests
Please note this pricing is correct for the Hascombe Farm Screening Clinic on 4th July and may vary between other events. All prices are inclusive of VAT.
Basic tests
£42
Total PSA
A widely accepted blood test used to measure the levels of prostate-specific antigen (PSA) in a man's blood to help screen for and monitor prostate health, including the presence of prostate cancer. The total PSA test measures the overall amount of PSA in the blood, including both forms that are bound to proteins and those that are not. Eligibility: anyone with a prostate, of any age.
£42
£72
Total and Free PSA
Measures the ratio of free PSA (not bound to proteins) to PSA bound to proteins. This improves the accuracy of prostate cancer screening and helps distinguish between cancer and benign prostate conditions such as benign prostatic hyperplasia (BPH). Eligibility: anyone with a prostate, of any age.
£72
£36
FIT test
A FIT (Fecal Immunochemical Test) checks for hidden blood in your stool, which can be a sign of colon cancer or other conditions. You'll collect a small stool sample at home and send it back to our laboratory. It's non-invasive, simple, and is critical for the early detection of colon issues. Eligibility: anyone over 18.
£36
Advanced tests
£228
Proclarix
Advanced screening test for prostate cancer, more accurate than PSA alone, used where the PSA is between 2-10ng/ml. This range is known as the diagnostic “grey zone”, as it is unclear whether the PSA level indicates prostate cancer or not. Developed in Sweden and used by top private consultants, Proclarix measures protein biomarkers in the blood alongside PSA to give a more accurate risk of prostate cancer. If you book a Proclarix test, we will firstly test your PSA. If your PSA is between 2-10ng/ml, we will run the full Proclarix test. If it is outside of this range, you will only pay for your total and free PSA test. Eligibility: PSA must be between 2-10ng/ml.
£228
£474
Stockholm3
Advanced screening test for prostate cancer including biomarkers and genetics. More accurate than PSA alone, Stockholm3 measures PSA, protein biomarkers and genetic markers to determine your risk of aggressive prostate cancer. It can be used where the PSA is between 1.5-20ng/ml. If your result is above the risk threshold, the results advise that you have further investigation (MRI). If you are at lowest risk, you don't need to retest for 6 years. If you book a Stockholm3 test, we will firstly test your PSA. If your PSA is between 1.5-20ng/ml, we will run the full Stockholm3 test. If it is outside of this range, you will only pay for your total and free PSA test. Eligibility: men over 45 with PSA between 1.5-20ng/ml.
£474
£180
EarlyCDT Lung
A non-invasive, advanced blood test that detects lung cancer on average of 4 years, and up to 9 years early than standard clinical diagnosis. It analyses biomarkers in the blood which are present at the very earliest stages of lung cancer, when it is treatable and prognosis is better. Eligibility: recommended for people who are at increased risk of lung cancer e.g., smoker/ex-smoker, exposure to secondhand smoke, radiation therapy, exposure to radon gas, exposure to asbestos and other carcinogens, exposure to any occupational risk of lung cancer, family history of lung cancer.
£180
£228
Bladder EpiCheck
A non-invasive urine used for early detection of bladder cancer. This advanced biomarker test analyses DNA methylation markers in the urine which indicate presence of a bladder tumour or Upper Tract Urothelial Carcinoma. Detecting these tumours at the earliest stages can allow for non-invasive treatments and good prognosis. Eligibility: Anyone who has experienced urinary tract symptoms or who is concerned about bladder cancer can do a n EpiCheck test. It can be done as part of a routine health check.
£228
£594
Genetic Screening
You give a simple saliva sample and your DNA is examined for the presence of 31 genetic variants that increase your risk of developing cancer. If a genetic variant is found, the report will provide the impact, implications, and recommended actions which will be fully explained to patients via the genetic counselling process. Knowing your genetic risk for different cancers allows you to make informed lifestyle choices and test regularly, meaning any tumours are likely to be found much earlier. It also allows your family to make informed choices around testing and lifestyle. Anyone over the age of 18, specifically recommended for those with family history of cancer.
£594
Basic tests
£36
FIT test
A FIT (Fecal Immunochemical Test) checks for hidden blood in your stool, which can be a sign of colon cancer or other conditions. You'll collect a small stool sample at home and send it back to our laboratory. It's non-invasive, simple, and is critical for the early detection of colon issues. Eligibility: anyone over 18.
£36
Advanced tests
£228
Bladder EpiCheck
A non-invasive urine used for early detection of bladder cancer. This advanced biomarker test analyses DNA methylation markers in the urine which indicate presence of a bladder tumour or Upper Tract Urothelial Carcinoma. Detecting these tumours at the earliest stages can allow for non-invasive treatments and good prognosis. Eligibility: Anyone who has experienced urinary tract symptoms or who is concerned about bladder cancer can do a n EpiCheck test. It can be done as part of a routine health check.
£228
£180
EarlyCDT Lung
The EarlyCDT Lung is a non-invasive, advanced blood test that detects lung cancer on average of 4 years, and up to 9 years early than standard clinical diagnosis. It analyses biomarkers in the blood which are present at the very earliest stages of lung cancer, when it is treatable and prognosis is better. Eligibility: recommended for people who are aged 45+ who are at increased risk of lung cancer e.g., smoker/ex-smoker, exposure to secondhand smoke, radiation therapy, exposure to radon gas, exposure to asbestos and other carcinogens, exposure to any occupational risk of lung cancer, family history of lung cancer. Can be used by younger people.
£180
£594
Genetic Screening
You give a simple saliva sample and your DNA is examined for the presence of 31 genetic variants that increase your risk of developing cancer. If a genetic variant is found, the report will provide the impact, implications, and recommended actions which will be fully explained to patients via the genetic counselling process. Knowing your genetic risk for different cancers allows you to make informed lifestyle choices and test regularly, meaning any tumours are likely to be found much earlier. It also allows your family to make informed choices around testing and lifestyle. Anyone over the age of 18, specifically recommended for those with family history of cancer.
£594
Need more information?
Would you like to know more before booking? Register your interest below or fill in the form with a specific enquiry and we will get back to you. Alternatively, you can contact us via our Facebook page, or our Whatsapp number +44 7714785644.